Skip to Content

Pharmaceuticals, Volume 7, Issue 6

2014 June - 5 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

  • Review
  • Open Access
132 Citations
23,275 Views
31 Pages

10 June 2014

Reptiles are among the oldest known amniotes and are highly diverse in their morphology and ecological niches. These animals have an evolutionarily ancient innate-immune system that is of great interest to scientists trying to identify new and usefu...

(This article belongs to the Special Issue Identification and Characterization of Antimicrobial Peptides with Therapeutic Potential)
  • Article
  • Open Access
17 Citations
13,813 Views
28 Pages

6 June 2014

The five tautomers of the drug acyclovir (ACV) were determined and optimised at the MP2 and B3LYP quantum chemical levels of theory. The stability of the tautomers was correlated with different parameters. On the most stable tautomer N1 was carried o...

(This article belongs to the Special Issue Prodrugs: from Design to Clinic)
  • Article
  • Open Access
2 Citations
12,604 Views
19 Pages

Part Two: Evaluation of N-methylbupropion as a Potential Bupropion Prodrug

  • Paul Matthew O'Byrne,
  • Robert Williams,
  • John J. Walsh and
  • John F. Gilmer

28 May 2014

N-methylbupropion was selected as a potential prodrug from our in vitro screening of analogues of bupropion described in the preceding paper. This study describes in vivo pharmacokinetics of N-methylbupropion in the guinea-pig animal model, which is...

(This article belongs to the Special Issue Prodrugs: from Design to Clinic)
  • Article
  • Open Access
9 Citations
8,186 Views
14 Pages

27 May 2014

Radiolabeled peptides which target tumor-specific membrane structures of cancer cells represent a promising class of targeted radiopharmaceuticals for the diagnosis and therapy of cancer. A potential drawback of a number of reported radiopeptides is...

(This article belongs to the Special Issue Radiopharmaceutical Chemistry between Imaging and Radioendotherapy)
  • Review
  • Open Access
42 Citations
17,596 Views
28 Pages

26 May 2014

Histone deacetylases (HDACs) enzymes, which affect the acetylation status of histones and other important cellular proteins, have been recognized as potentially useful therapeutic targets for a broad range of human disorders. Emerging studies have de...

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247